| Subscribe | | | Archives |
Have a question?
If you have needs specifically related to this newsletter's content, send us an email to have a Deloitte Tax professional contact you.
Tax
Tax News & Views
February 17, 2012
DBriefs webcast: Proposed medical device excise tax regs may have broad implications for affected companies
The Internal Revenue Service released proposed regulations February 3 addressing the new 2.3 percent excise tax on medical device sales that was enacted in the 2010 health care reform legislation and takes effect beginning January 1, 2013. (For prior coverage on the proposed regulations, see Tax News & Views, Vol. 13, No. 5, Feb. 10, 2012.)
A recent DBriefs webcast from Deloitte Tax LLP looks at issues that affected companies should consider in addressing the new proposed rules, including:
- The types of devices subject to the medical device excise tax and clarifications on retail and other exemptions;
- Common issues arising as organizations prepare for the new tax, such as the taxable price and taxable uses of products, kits, and combination products; and
- Potential compliance challenges and a practical approach to addressing them.
View the playback of this webcast to understand more about the impact of the new proposed regulations on affected companies.
— Michael DeHoff
Tax Policy Group
Deloitte Tax LLP
This publication contains general information only, and none of Deloitte Touche Tohmatsu Limited, its member firms, or its and their affiliates are, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your finances or your business. Before making any decision or taking any action that may affect your finances or your business, you should consult a qualified professional adviser. None of Deloitte Touche Tohmatsu Limited, its member firms, or its and their respective affiliates shall be responsible for any loss whatsoever sustained by any person who relies on this publication.
As used in this document, “Deloitte” means Deloitte Tax LLP. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu and its member firms.
Deloitte.com | Unsubscribe | Manage E-mail Preferences | RSS 
1633 Broadway
New York, NY 10019-6754
United States
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
Copyright © 2012 Deloitte Development LLC. All rights reserved.
Member of Deloitte Touche Tohmatsu Limited
Security | Legal | Privacy